ConductScience.org, home

Paper16734731

High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer.

Miyoshi Y and 7 others. Cancer Sci, 2006. Cited by 89 papers, by iCite.

Cite this record

ConductScience Library. High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer. Papers, record 16734731. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16734731

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
High expression of ubiquitin carboxy-terminal hydrolase-L1 and -L3 mRNA predicts early recurrence in patients with invasive breast cancer.
PubMed
Journal
Cancer Sci
PubMed
Year
2006
PubMed
Publication types
Comparative Study, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
89
iCite
Relative citation ratio, by iCite
1.84
iCite
Revised in PubMed
2024-06-09
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Miyoshi YYasuo
2Nakayama SSatoshi
3Torikoshi YYasuhiro
4Tanaka SSatoshi
5Ishihara HHideki
6Taguchi TTetsuya
7Tamaki YYasuhiro
8Noguchi SShinzaburo

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biomarkers, TumorMajor topic
Breast NeoplasmsMajor topic
Neoplasm Recurrence, LocalMajor topic
Ubiquitin ThiolesteraseMajor topic
Antigens, CD
Female
Humans
Postmenopause
Premenopause
Prognosis
RNA, Messenger
Receptors, Estrogen
Receptors, Progesterone
Reverse Transcriptase Polymerase Chain Reaction

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
19865724Serial analysis of gene expression in non-small cell lung cancer.Cancer Res1998https://conductscience.org/library/papers/9865724PubMed
215491288Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells.Br J Haematol2004https://conductscience.org/library/papers/15491288PubMed
32551477Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas.Cancer1989https://conductscience.org/library/papers/2551477PubMed
49521656Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases.Biochemistry1998https://conductscience.org/library/papers/9521656PubMed
51426603Comparisons of neuronal (PGP 9.5) and non-neuronal ubiquitin C-terminal hydrolases.Biochem Soc Trans1992https://conductscience.org/library/papers/1426603PubMed
69614804Adjuvant Therapy of Primary Breast Cancer, 6th International Conference. Olma Messen St. Gallen. February 25-28, 1998. Abstracts.Eur J Cancer1998https://conductscience.org/library/papers/9614804PubMed
712507557Human papillomavirus-induced carcinogenesis and the ubiquitin-proteasome system.Semin Cancer Biol2003https://conductscience.org/library/papers/12507557PubMed
810713173Expression and functional analysis of Uch-L3 during mouse development.Mol Cell Biol2000https://conductscience.org/library/papers/10713173PubMed
911801558PGP9.5 as a marker for invasive colorectal cancer.Clin Cancer Res2002https://conductscience.org/library/papers/11801558PubMed
1011773260Expression of the protein gene product 9.5, PGP9.5, is correlated with T-status in non-small cell lung cancer.Jpn J Clin Oncol2001https://conductscience.org/library/papers/11773260PubMed
1112408865The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility.Cell2002https://conductscience.org/library/papers/12408865PubMed
128541094Fifth International Conference on Adjuvant Therapy of Breast Cancer, St Gallen, March 1995. International Consensus Panel on the Treatment of Primary Breast Cancer.Eur J Cancer1995https://conductscience.org/library/papers/8541094PubMed
139018245Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.Nat Med1997https://conductscience.org/library/papers/9018245PubMed
149472642The ubiquitin-proteasome pathway in cancer.Br J Cancer1998https://conductscience.org/library/papers/9472642PubMed
1514571718PGP9.5 overexpression in esophageal squamous cell carcinoma.Hepatogastroenterology2003https://conductscience.org/library/papers/14571718PubMed
169018244Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer.Nat Med1997https://conductscience.org/library/papers/9018244PubMed
1712082530Interaction and colocalization of PGP9.5 with JAB1 and p27(Kip1).Oncogene2002https://conductscience.org/library/papers/12082530PubMed
182530630The neuron-specific protein PGP 9.5 is a ubiquitin carboxyl-terminal hydrolase.Science1989https://conductscience.org/library/papers/2530630PubMed
1911158620Complete switch from Mdm2 to human papillomavirus E6-mediated degradation of p53 in cervical cancer cells.Proc Natl Acad Sci U S A2001https://conductscience.org/library/papers/11158620PubMed
2014962731PGP9.5 mRNA could contribute to the molecular-based diagnosis of medullary thyroid carcinoma.Eur J Cancer2004https://conductscience.org/library/papers/14962731PubMed

See all 22 referencesDownload CSV of references

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 89 citations.

PMIDTitleJournalYearIn PapersSource
41945287UCHL3 Promotes Triple-Negative Breast Cancer Metastatic Potential Through Enhancing Cell Migration and Invasion.Appl Biochem Biotechnol2026https://conductscience.org/library/papers/41945287PubMed
41578740Targeting UCHL3 attenuates pathological markers in neuronal models of Huntington's disease.Brain2026https://conductscience.org/library/papers/41578740PubMed
41271634UCHL3 depletion inhibits gastric cancer progression and enhances palbociclib sensitivity by regulating the AKT/CCND1 signaling axis via ENO1 ubiquitination.Cell Death Dis2025https://conductscience.org/library/papers/41271634PubMed
40691601UCHL3: a crucial deubiquitinase in DNA damage repair and tumor progression.Cancer Cell Int2025https://conductscience.org/library/papers/40691601PubMed
40141757Proteasomes and Ubiquitin C-Terminal Hydrolase L1 as Biomarkers of Tissue Damage and Inflammatory Response to Different Types of Injury-A Short Review.Life (Basel)2025https://conductscience.org/library/papers/40141757PubMed
39005671Potential roles of UCH family deubiquitinases in tumorigenesis and chemical inhibitors developed against them.Am J Cancer Res2024https://conductscience.org/library/papers/39005671PubMed
36844618Ubiquitin C‑terminal hydrolase‑L1: A new cancer marker and therapeutic target with dual effects (Review).Oncol Lett2023https://conductscience.org/library/papers/36844618PubMed
36142702Structural Insights into the Phosphorylation-Enhanced Deubiquitinating Activity of UCHL3 and Ubiquitin Chain Cleavage Preference Analysis.Int J Mol Sci2022https://conductscience.org/library/papers/36142702PubMed
34745437UCH-L1 and UCH-L3 regulate the cancer stem cell-like properties through PI3 K/Akt signaling pathway in prostate cancer cells.Anim Cells Syst (Seoul)2021https://conductscience.org/library/papers/34745437PubMed
34539860UCHL3 plays an important role in the occurrence and development of melanoma.Oncol Lett2021https://conductscience.org/library/papers/34539860PubMed
34497382UCHL1 as a novel target in breast cancer: emerging insights from cell and chemical biology.Br J Cancer2022https://conductscience.org/library/papers/34497382PubMed
33995103Extracellular Vesicles: A Novel Tool Facilitating Personalized Medicine and Pharmacogenomics in Oncology.Front Pharmacol2021https://conductscience.org/library/papers/33995103PubMed
33668938Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1.Molecules2021https://conductscience.org/library/papers/33668938PubMed
33585209Ubiquitin Carboxyl-Terminal Hydrolases and Human Malignancies: The Novel Prognostic and Therapeutic Implications for Head and Neck Cancer.Front Oncol2020https://conductscience.org/library/papers/33585209PubMed
33438509UCHL1, a deubiquitinating enzyme, regulates lung endothelial cell permeability in vitro and in vivo.Am J Physiol Lung Cell Mol Physiol2021https://conductscience.org/library/papers/33438509PubMed
32656641Behr syndrome and hypertrophic cardiomyopathy in a family with a novel UCHL1 deletion.J Neurol2020https://conductscience.org/library/papers/32656641PubMed
32546741The deubiquitylase UCHL3 maintains cancer stem-like properties by stabilizing the aryl hydrocarbon receptor.Signal Transduct Target Ther2020https://conductscience.org/library/papers/32546741PubMed
32042339UCH-L1-mediated Down-regulation of Estrogen Receptor α Contributes to Insensitivity to Endocrine Therapy for Breast Cancer.Theranostics2020https://conductscience.org/library/papers/32042339PubMed
31906456Ubiquitin Carboxyl-Terminal Hydrolase L1 (UCHL1) Promotes Uterine Serous Cancer Cell Proliferation and Cell Cycle Progression.Cancers (Basel)2020https://conductscience.org/library/papers/31906456PubMed
31598398UCHL3 promotes pancreatic cancer progression and chemo-resistance through FOXM1 stabilization.Am J Cancer Res2019https://conductscience.org/library/papers/31598398PubMed

See all 43 cited byDownload CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ESR12099PubTator's text mininghttps://conductscience.org/library/genes/2099NCBI Gene
PGR5241PubTator's text mininghttps://conductscience.org/library/genes/5241NCBI Gene
UCHL17345PubTator's text mininghttps://conductscience.org/library/genes/7345NCBI Gene
UCHL37347PubTator's text mininghttps://conductscience.org/library/genes/7347NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16734731

GET https://conductscience.org/api/papers/v1/16734731/references?page=2